Caption Management, LLC - CLARUS THERAPEUTICS HLDNGS I ownership

Back to all holdings Add to watchlist

CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L115. A total of 20 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Caption Management, LLC ownership history of CLARUS THERAPEUTICS HLDNGS I
ValueSharesWeighting
Q3 2022$0
-100.0%
140,8210.0%0.00%–
Q2 2022$11,000
-45.0%
140,8210.0%0.00%–
Q1 2022$20,000
-51.2%
140,8210.0%0.00%–
Q4 2021$41,000
-61.3%
140,8210.0%0.00%
-100.0%
Q3 2021$106,000–140,821–0.00%–
 Download
Other shareholders
CLARUS THERAPEUTICS HLDNGS I shareholders Q2 2022
NameSharesValueWeighting ↓
Tower Research Capital LLC (TRC) 91$00.00%
NOMURA HOLDINGS INC 85,000$00.00%
Context Capital Management, LLC 62,175$00.00%
MIZUHO SECURITIES USA LLC 100,000$1,0000.00%
Caption Management, LLC 140,821$00.00%
View complete list of CLARUS THERAPEUTICS HLDNGS I shareholders